<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Comabella M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Chitinase 3-like 1 (CHI3L1) is a prognostic biomarker in multiple sclerosis (MS). However, its clinical application is limited by a lack of standardized detection methods and concerns about preanalytical variability.&lt;h4>Objectives&lt;/h4>This study aims to evaluate the impact of preanalytical factors (delayed processing of blood and repeated thawing/freezing) on serum CHI3L1 levels. Additionally, we sought to correlate CHI3L1 blood and cerebrospinal fluid (CSF) levels and identified its cellular source in peripheral blood mononuclear cells (PBMCs) from MS patients.&lt;h4>Methods&lt;/h4>We used an in-house Single Molecule Array (Simoa) assay to measure CHI3L1 levels in serum, plasma, and CSF from MS patients and controls. The source of CHI3L1 production in PBMCs was determined by </pubmed_abstract><journal>Frontiers in immunology</journal><pagination>1720914</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12907172</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of preanalytical factors on blood CHI3L1 levels.</pubmed_title><pmcid>PMC12907172</pmcid><pubmed_authors>Castillo M</pubmed_authors><pubmed_authors>Aroca M</pubmed_authors><pubmed_authors>Comabella M</pubmed_authors><pubmed_authors>Gutierrez L</pubmed_authors><pubmed_authors>Eixarch H</pubmed_authors><pubmed_authors>Fissolo N</pubmed_authors><pubmed_authors>Montalban X</pubmed_authors><pubmed_authors>La Puma D</pubmed_authors><pubmed_authors>Vilaseca A</pubmed_authors><pubmed_authors>Villar LM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of preanalytical factors on blood CHI3L1 levels.</name><description>&lt;h4>Background&lt;/h4>Chitinase 3-like 1 (CHI3L1) is a prognostic biomarker in multiple sclerosis (MS). However, its clinical application is limited by a lack of standardized detection methods and concerns about preanalytical variability.&lt;h4>Objectives&lt;/h4>This study aims to evaluate the impact of preanalytical factors (delayed processing of blood and repeated thawing/freezing) on serum CHI3L1 levels. Additionally, we sought to correlate CHI3L1 blood and cerebrospinal fluid (CSF) levels and identified its cellular source in peripheral blood mononuclear cells (PBMCs) from MS patients.&lt;h4>Methods&lt;/h4>We used an in-house Single Molecule Array (Simoa) assay to measure CHI3L1 levels in serum, plasma, and CSF from MS patients and controls. The source of CHI3L1 production in PBMCs was determined by </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-07-16T05:05:35.162Z</modification><creation>2026-07-09T10:38:12.087Z</creation></dates><accession>S-EPMC12907172</accession><cross_references><pubmed>41704533</pubmed><doi>10.3389/fimmu.2025.1720914</doi></cross_references></HashMap>